Amphastar Pharma (AMPH) Tops Q4 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Amphastar Pharma (AMPH) Tops Q4 EPS by 7c

Amphastar Pharmaceuticals Reports Revenues of $55.9 Million for the Fourth Quarter Ended December 31, 2014

March 24, 2015 4:01 PM EDT

RANCHO CUCAMONGA, Calif., March 24, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq: AMPH) ("Amphastar" or the "Company") today reported results for the fourth quarter ended December 31, 2014.

Net revenues of $55.9 million for the fourth quarter GAAP net loss of $2.5 million, or $0.06 per diluted share for the fourth quarter Adjusted non-GAAP net loss of $1.5 million, or $0.03 per diluted share for the fourth quarter   Three Months Ended December 31, Years Ended December 31,   2014 2013 2014 2013   (in thousands, except per share data) Net revenues... More